Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear …
Over the last 12 months, insiders at Prestige Consumer Healthcare Inc. have bought $0 and sold $6M worth of Prestige Consumer Healthcare Inc. stock.
On average, over the past 5 years, insiders at Prestige Consumer Healthcare Inc. have bought $0 and sold $4.41M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,500 shares for transaction amount of $50,850 was made by P'Pool William (SVP, Gen Counsel & Corp Sec.) on 2018‑02‑12.
2024-03-01 | Sale | SVP Quality & Regulatory | 172 0.0003% | $70.42 | $12,112 | +0.43% | ||
2024-02-28 | Sale | SVP Quality & Regulatory | 662 0.0013% | $70.30 | $46,537 | +1.20% | ||
2024-02-27 | Sale | SVP Quality & Regulatory | 1 <0.0001% | $70.00 | $70 | +0.77% | ||
2024-02-26 | Sale | SVP Quality & Regulatory | 9,677 0.0196% | $70.43 | $681,597 | +0.54% | ||
2024-02-23 | Sale | SVP Quality & Regulatory | 11 <0.0001% | $70.00 | $770 | +0.86% | ||
2024-02-15 | Sale | EVP, Marketing & Sales | 15,549 0.0319% | $69.11 | $1.07M | +1.98% | ||
2024-02-14 | Sale | See remarks | 26,019 0.0523% | $67.90 | $1.77M | +3.60% | ||
2024-02-14 | Sale | Chief Financial Officer | 30,019 0.0608% | $68.35 | $2.05M | +3.60% | ||
2024-02-08 | Sale | SVP Quality & Regulatory | 5,336 0.0118% | $69.00 | $368,184 | +1.86% | ||
2023-09-14 | Sale | SVP Quality & Regulatory | 2,540 0.0051% | $58.92 | $149,657 | +10.27% | ||
2023-08-08 | Sale | Chief Executive Officer | 32,800 0.0673% | $65.57 | $2.15M | -2.47% | ||
2023-05-24 | Sale | Chief Financial Officer | 44,011 0.0894% | $60.07 | $2.64M | +1.70% | ||
2023-05-19 | Sale | EVP, Marketing & Sales | 17,194 0.0346% | $60.27 | $1.04M | +0.30% | ||
2023-05-15 | Sale | SVP Quality & Regulatory | 8,154 0.0164% | $58.80 | $479,455 | +2.59% | ||
2022-12-06 | Sale | SVP, GC & Corp Secretary | 14,780 0.0297% | $60.76 | $898,033 | -1.17% | ||
2022-12-02 | Sale | SVP, GC & Corp Secretary | 13,862 0.0278% | $63.60 | $881,623 | -5.84% | ||
2022-12-01 | Sale | SVP Quality & Regulatory | 7,114 0.014% | $61.57 | $438,009 | -4.18% | ||
2022-11-18 | Sale | Chief Executive Officer | 38,793 0.0772% | $59.10 | $2.29M | +0.94% | ||
2021-11-12 | Sale | Chief Executive Office | 52,367 0.1042% | $62.78 | $3.29M | -10.11% | ||
2021-03-05 | Sale | Senior VP Quality & Regulatory | 5,759 0.0113% | $42.80 | $246,485 | +28.85% |
P'Pool William | See remarks | 24917 0.0503% | $77.53 | 1 | 3 | +6.17% |
Mann Peter | director | 440390 0.8886% | $77.53 | 2 | 3 | <0.0001% |
Anderson Peter | Chief Financial Officer | 359761 0.7259% | $77.53 | 1 | 1 | <0.0001% |
Butler Gerard | Chief Sales Officer | 289172 0.5835% | $77.53 | 2 | 1 | +12.53% |
Lombardi Ronald M. | Chief Executive Officer | 270557 0.5459% | $77.53 | 2 | 12 | +27.81% |
BlackRock | $633.54M | 17.58 | 8.73M | -3.72% | -$24.48M | 0.01 | |
The Vanguard Group | $416.64M | 11.56 | 5.74M | -0.24% | -$1.03M | 0.01 | |
Dimensional Fund Advisors | $229M | 6.35 | 3.16M | -8.11% | -$20.2M | 0.06 | |
Macquarie Group | $211.87M | 5.88 | 2.92M | -4.66% | -$10.35M | 0.19 | |
Ariel Investments | $185.83M | 5.16 | 2.56M | +0.2% | +$378,327.84 | 1.83 |